MiRNA therapeutics based on logic circuits of biological pathways

作者: Valeria Boscaino , Antonino Fiannaca , Laura La Paglia , Massimo La Rosa , Riccardo Rizzo

DOI: 10.1186/S12859-019-2881-7

关键词:

摘要: In silico experiments, with the aid of computer simulation, speed up process in vitro or vivo experiments. Cancer therapy design is often based on signalling pathway. MicroRNAs (miRNA) are small non-coding RNA molecules. several kinds diseases, including cancer, hepatitis and cardiovascular they deregulated, acting as oncogenes tumor suppressors. miRNA therapeutics two main molecules injection: mimics, which consists injection that mimic targeted miRNA, antagomiR, inhibiting miRNA. Nowadays, research focused therapeutics. This paper addresses cancer related pathways to investigate order prove our approach, we present different case studies: non-small cell lung melanoma. KEGG modelled by a digital circuit. A logic value 1 linked expression corresponding gene. 0 absence (not expressed) All possible relationships provided pathway gates. Mutations, derived according literature, introduced well. The modelling approach analysis widely discussed within paper. MiRNA investigated circuit analysis. most effective combination miRNAs, terms reduction pathogenic conditions, obtained. discussion obtained results comparison literature data provided. Results confirmed existing data. proposed study drug discovery uses simulation Using this drugs miRNAs for mutated these were validated literature. can be applied each human disease, starting from

参考文章(80)
John M Graham, Robert Conway, William B Dobyns, Ghayda Mirzaa, PIK3CA-Related Segmental Overgrowth University of Washington, Seattle. ,(2013)
Matteo Brioschi, John Fischer, Roberto Cairoli, Stefano Rossetti, Laura Pezzetti, Michele Nichelatti, Mauro Turrini, Francesca Corlazzoli, Barbara Scarpati, Enrica Morra, Nicoletta Sacchi, Alessandro Beghini, Down-regulation of MicroRNAs 222/221 in Acute Myelogenous Leukemia with Deranged Core-Binding Factor Subunits Neoplasia. ,vol. 12, pp. 866- 876 ,(2010) , 10.1593/NEO.10482
J. R. Buchan, R. Parker, The Two Faces of miRNA Science. ,vol. 318, pp. 1877- 1878 ,(2007) , 10.1126/SCIENCE.1152623
Omer An, Giovanni M. Dall'Olio, Thanos P. Mourikis, Francesca D. Ciccarelli, NCG 5.0: updates of a manually curated repository of cancer genes and associated properties from cancer mutational screenings Nucleic Acids Research. ,vol. 44, pp. 992- 999 ,(2016) , 10.1093/NAR/GKV1123
KJ Champion, C Bunag, AL Estep, JR Jones, CH Bolt, RC Rogers, KA Rauen, DB Everman, Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome. Clinical Genetics. ,vol. 79, pp. 468- 474 ,(2011) , 10.1111/J.1399-0004.2010.01495.X
David Dankort, David P Curley, Robert A Cartlidge, Betsy Nelson, Anthony N Karnezis, William E Damsky Jr, Mingjian J You, Ronald A DePinho, Martin McMahon, Marcus Bosenberg, BrafV600E cooperates with Pten loss to induce metastatic melanoma Nature Genetics. ,vol. 41, pp. 544- 552 ,(2009) , 10.1038/NG.356
Jon C. Henry, Ana Clara P. Azevedo-Pouly, Thomas D. Schmittgen, microRNA Replacement Therapy for Cancer Pharmaceutical Research. ,vol. 28, pp. 3030- 3042 ,(2011) , 10.1007/S11095-011-0548-9
Phong Trang, Jason F Wiggins, Christopher L Daige, Chris Cho, Michael Omotola, David Brown, Joanne B Weidhaas, Andreas G Bader, Frank J Slack, Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice Molecular Therapy. ,vol. 19, pp. 1116- 1122 ,(2011) , 10.1038/MT.2011.48
Carl Burch, Logisim Journal on Educational Resources in Computing. ,vol. 2, pp. 5- 16 ,(2002) , 10.1145/545197.545199
Ryo Yamashita, Mitsuo Sato, Tomohiko Kakumu, Tetsunari Hase, Naoyuki Yogo, Eiichi Maruyama, Yoshitaka Sekido, Masashi Kondo, Yoshinori Hasegawa, Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells. Cancer Medicine. ,vol. 4, pp. 551- 564 ,(2015) , 10.1002/CAM4.412